Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Journal of General Internal Medicine|July 9, 2025
Imaging of Medical Patients with Acute Kidney Injury: Patterns of Ultrasound Use and the Role of Point-of-care Ultrasound at a Tertiary Care CenterMathilde Gaudreau-Simard, Sydney Ruller, Melissa Dann, et al.
Journal of Inherited Metabolic Disease|June 2, 2011
Variability in the clinical management of fatty acid oxidation disorders: results of a survey of Canadian metabolic physiciansBeth K Potter, Julian Little, Pranesh Chakraborty, et al.
Medical Oncology (Northwood, London, England)|September 13, 2013
Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapyBetsan M Thomas, Christian Smith, Jessica Evans, et al.
Environment International|March 12, 2026
Heatwaves and PM<sub>2.5</sub> from wildfire smoke, non-wildfire sources, and all sources in relation to preterm birth: a nationwide cohort study in CanadaQingyi Lan, Sarah Henderson, Eric Coker, et al.
Plos One|August 19, 2021
RNAi suppression of xylan synthase genes in wheat starchy endospermMark D Wilkinson, Ondrej Kosik, Kirstie Halsey, et al.
European Urology|December 4, 2014
SUCCINCT: an open-label, single-arm, non-randomised, phase 2 trial of gemcitabine and cisplatin chemotherapy in combination with sunitinib as first-line treatment for patients with advanced urothelial carcinomaThomas Geldart, John Chester, Angela Casbard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 25, 2015
Randomized Phase III Trial of Standard Therapy Plus Low Molecular Weight Heparin in Patients With Lung Cancer: FRAGMATIC TrialFergus Macbeth, Simon Noble, Jessica Evans, et al.
British Journal of Cancer|September 22, 2017
Comparison between MRI and pathology in the assessment of tumour regression grade in rectal cancerFrancesco Sclafani, Gina Brown, David Cunningham, et al.
Plos One|June 1, 2011
Clinical Clostridium difficile: clonality and pathogenicity locus diversityKate E Dingle, David Griffiths, Xavier Didelot, et al.
Health Technology Assessment (Winchester, England)|October 23, 2015
A feasibility study to inform the design of a randomised controlled trial to identify the most clinically effective and cost-effective length of Anticoagulation with Low-molecular-weight heparin In the treatment of Cancer-Associated Thrombosis (ALICAT)Simon I Noble, Annmarie Nelson, David Fitzmaurice, et al.
Pageof 5